Venture Life Group (VLG.L) Stock Analysis & Winston Score
Venture Life Group is a UK-based healthcare company that develops and sells consumer healthcare products — things like oral care, skincare, and personal hygiene items that people buy without a prescription. Its products are sold under its own brands as well as manufactured for other companies under private-label arrangements, meaning retailers or other brands put their own name on Venture Life's products. The company serves pharmacies, retailers, and healthcare professionals mainly across Europe. Venture Life makes money by selling finished products directly and by manufacturing products for third-party clients, giving it two revenue streams. It operates primarily in the UK and continental Europe and is a small company with a market cap around $100 million. Its competitive position relies on owning niche product formulations and having established distribution relationships, but with an operating margin of just 3% and a very low return on invested capital, the main risk is that thin profitability leaves little room for error if costs rise or sales growth slows.
Winston Score: 42/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (9/30)
- Growth: Mixed (7/20)
- Cash Flow: Weak (1/10)
- Stability: Good (5/10)
- Valuation: Strong (7/10)
- Ownership: Good (10/15)
Key Facts
Price: 66.00 GBp
Market Cap: £80M
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: London Stock Exchange



